Hasty Briefsbeta

  • #public health
  • #vaccination
  • #COVID-19
  • COVID booster shots significantly reduce risks of emergency visits, hospitalizations, and death.
  • 2024–2025 mRNA vaccines showed 29%–64% effectiveness, lower than the initial 94% in 2019.
  • Vaccines were effective across all age groups and for people with or without chronic conditions.
  • New 2025–2026 vaccines target the LP.8.1 variant, with Spikevax showing higher antibody levels than COMIRNATY.
  • Vaccination rates are declining, but experts emphasize the continued benefits of getting vaccinated.
  • The study highlights the importance of vaccination for younger and healthy individuals, not just high-risk groups.